Apple Tree Partners
Overview
Apple Tree Partners (ATP) is a leader in life sciences venture capital, with a 25-year track record of translating emerging scientific advances into novel innovative treatments. ATP creates companies starting at various stages: from working with scientists on pre-IP ideas, to spinouts from existing company pipelines. We provide flexible capital, strategic insight, and operational resources to build sustainable, research-driven enterprises. We invest in our companies from seed stage through IPO and beyond, and we support our management teams in strategic transactions and synergistic business combinations.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Gala Therapeutics | Sep 2025 | Series C | Co-investor |
| Galvanize Therapeutics | Sep 2025 | Series C | Co-investor |
| Green Hydrogen Systems A/S | Dec 2024 | Debt | Co-investor |
| Red Queen Therapeutics | Aug 2024 | Grant | Lead |
| Deep Apple Therapeutics | Dec 2023 | Series A | Lead |
Key People
Andrew Bayliffe
Venture Partner
Mark Mitchnick
Venture Partner
Paul Eisenberg
Venture Partner
Aileen Salares
Principal
Stephanie Maiocco
Principal Scientist
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
